These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 31128197)

  • 1. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
    Sharma M; Sharma R; Jain DK; Saraf A
    Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
    Ghassemi S; Haeri A; Shahhosseini S; Dadashzadeh S
    AAPS PharmSciTech; 2018 Oct; 19(7):2961-2970. PubMed ID: 30030724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
    Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
    Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
    Saroha A; Pandey P; Kaushik D
    Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of oral bioavailability of carvedilol by liquisolid compact: optimization and pharmacokinetic study.
    Jhaveri M; Nair AB; Shah J; Jacob S; Patel V; Mehta T
    Drug Deliv Transl Res; 2020 Aug; 10(4):975-985. PubMed ID: 32124413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
    Patil SS; Roy K; Choudhary B; Mahadik KR
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 12. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate:
    Aljaeid BM; El-Say KM; Hosny KM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Krishna VM; Kumar VB; Dudhipala N
    Pharm Nanotechnol; 2020; 8(3):207-224. PubMed ID: 32416685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments.
    Rahat I; Imam SS; Rizwanullah M; Alshehri S; Asif M; Kala C; Taleuzzaman M
    Drug Deliv; 2021 Dec; 28(1):973-984. PubMed ID: 34036860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, Characterization, and Selection of Optimal Forms of (S)-Carvedilol Salts for the Development of Extended-Release Formulation.
    Zhang Q; Huang B; Xue H; Lin Z; Zhao J; Cai Z
    Mol Pharm; 2021 Jun; 18(6):2298-2310. PubMed ID: 34032449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits.
    El-Say KM; Hosny KM
    PLoS One; 2018; 13(8):e0203405. PubMed ID: 30161251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
    Gajra B; Patel RR; Dalwadi C
    Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
    Patil GB; Surana SJ
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
    Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.